Newly created position to lead efforts focused on continued growth and salesSOMERSET, N.J., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell ...
New data will showcase significantly increased and sustained minimal residual disease (MRD) negativity rates, reinforcing the potential of ...
In a report released today, Asthika Goonewardene from Truist Financial maintained a Buy rating on Legend Biotech (LEGN – Research ...
The companies’ CAR-T seemed to cause fewer movement disorders in a multiple myeloma trial than J&J's Carvykti has in other ...
AstraZeneca is under scrutiny in China — as its top executive there and other personnel are being investigated by authorities ...
Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for ...
What are scientists scared of? Delve into three biotech sci-fi-inspired scenarios that might make you fear progress.
An FDA announcement last year of an investigation into the risk of patients developing secondary cancers following the ...
Viking Therapeutics (VKTX) stock is reversing gains despite earlier announcing strong results for its experimental obesity pill ...
Bristol Myers’ $1.5 billion restructuring initiative that runs through 2025 may not be the end of the company’s ongoing efficiency push. | Bristol Myers' $1.5 billion restructuring initiative that ...
Polysciences, Inc., headquartered in Warrington, PA, is a leader in the development and manufacturing of… The staffing industry needed a makeover. In 2018, Keli Price and Emily Zagar decided to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback